Thetis Pharmaceuticals LLC ("Thetis"), a clinical-stage company developing TP-317, a first-in-class, small molecule drug candidate targeting the BLT1 receptor to treat inflammatory bowel disease (IBD) ...

JAMA study confirms that vaccines measurably alter menstrual cycle timing, offering direct evidence of neuroendocrine effects ...

Boosting vitamin B12 levels can protect against acute pancreatitis by energizing pancreatic cells and preventing tissue ...